TherapeuticsMD, Inc. Common Stock (NASDAQ: TXMD) last traded at $2.06, up 0.00% on the session. The quote above updates while this page is open; the figures below are drawn from TherapeuticsMD, Inc. Common Stock’s own filings and are restated only when a new one is published.
TherapeuticsMD, Inc. Common Stock trades on NASDAQ under the ticker TXMD. Its market capitalisation is $23.84 million.
Valuation measures for TherapeuticsMD, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $23.84M |
|---|---|
| Enterprise value | $28.50M |
| Price / sales | 7.29 |
| Price / book | 0.88 |
| Beta | 0.23 |
Trailing-twelve-month figures tagged in TherapeuticsMD, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $3.27M |
|---|---|
| Net income (TTM) | -$217.0K |
| EPS (TTM) | -$0.0200 |
| Operating margin | -120.89% |
| Return on equity | -0.80% |
| Cash | $5.75M |
Range and volume for TXMD over the past 52 weeks.
| 52-week high | $2.95 |
|---|---|
| 52-week low | $0.990 |
| Volume | 3.4K |
| Average volume | 38.2K |
| Previous close | $2.06 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.